¹û¶³Ó°Ôº

At Annual Meeting of the ISMRM in London, May 2022

Ìý

About Us

The Magnetic Resonance Imaging (MRI) Group develops MRI techniques to increase image contrast and resolution by exploiting new contrast mechanisms. The research has applications in terms ofÌýimprovingÌýdiseaseÌýdiagnosis and ensuring therapies are effective.
While conventional MRI uses only the signal magnitude, utilising the frequency (or phase) of the MRI signal has dramatically improved visualisation of tissue structure and can also reveal tissue composition.Ìý

Researchers in the group have developed new methods of calculating tissue magnetic susceptibility maps from MRI frequency images, and are now aiming to unlock the potential of these methods to generate clinical biomarkers of disease.Ìý

Funded Research Projects

Developing Integrated Susceptibility and Conductivity MRI for Next Generation Structural and Functional Neuroimaging, ERC

Developing MRI Magnetic Susceptibility-Based Cancer Oxygenation Mapping (SBCOM) and Investigating its Clinical Potential to Measure Hypoxia in Prostrate Cancer (PCa), CRUK

• Professor Shonit Punwani

Software

Software for MRI phase unwrapping using SEGUE is freely downloadable at:Ìý

Software for QSM reconstruction methods is freely downloadable at:Ìý

Public Engagement

• Dr Anita Karsa’s award-winning MRI videos:
• Article on Prof Shmueli’s ERC grant in EU Research Magazine:
• Prof Karin Shmueli’s podcast on her MRI research:

The MRI Research Group over the yearsÌý

Ìý